Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.48 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | PTGES | O14684 | 2/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.45 |
| ▸ | PTGER1 | P34995 | 4/20 | 0.45 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.45 |
| ▸ | PTGER3 | P43115 | 3/20 | 0.45 |
| ▸ | PTGER2 | P43116 | 3/20 | 0.45 |
| ▸ | PDK1 | Q15118 | 4/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6778305 | 0.91 | LTB4R2 (0.52) | LMNAALDH1A1LTB4R2FFAR1FFAR4 | |
| SCHEMBL6783999 | 0.85 | PTGER1 (0.47) | LTB4R2ABCB1PTGESALOX5PTGER1 | |
| SCHEMBL6781046 | 0.84 | MEN1 (0.49) | LMNAALDH1A1LTB4R2PTGESALOX5 | |
| SCHEMBL6779695 | 0.83 | LMNA (0.49) | LMNAALDH1A1LTB4R2PTGESALOX5 | |
| SCHEMBL6778364 | 0.81 | PTGES (0.56) | LMNAALDH1A1LTB4R2PTGESALOX5 | |
| SCHEMBL6784549 | 0.81 | LTB4R2 (0.48) | LMNAALDH1A1LTB4R2PTGESALOX5 | |
| SCHEMBL6785117 | 0.79 | TSHR (0.49) | ALDH1A1PTGER1PTGER4PTGER3PTGER2 | |
| SCHEMBL6775891 | 0.79 | PDK1 (0.47) | ALDH1A1LTB4R2PDK1LPAR1 | |
| SCHEMBL6780300 | 0.79 | LTB4R2 (0.46) | LMNAALDH1A1LTB4R2PTGESALOX5 | |
| SCHEMBL6774063 | 0.79 | LTB4R2 (0.50) | LMNAALDH1A1LTB4R2PTGESALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020156281-A1 | Amide inhibitors of microsomal triglyceride transfer protein | BOOTH RICHARD JOHN (US) | 2002-10-24 | — | — | US | claimed |
| US-6780883-B2 | ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS | WARNER-LAMBERT COMPANY | 2004-08-24 | — | — | US | disclosed |
| US-20020156281-A1 | Amide inhibitors of microsomal triglyceride transfer protein | BOOTH RICHARD JOHN (US) | 2002-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156281-A1 | Amide inhibitors of microsomal triglyceride transfer protein | CETP, MTTP, LCAT | LMNA 4203/4885ALDH1A1 646/4885LTB4R2 1613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.